Aurinia Pharmaceuticals AUPH Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's change in inventories?
- Aurinia Pharmaceuticals (AUPH) reported change in inventories of $720K in Q1 2026.
- How has Aurinia Pharmaceuticals's change in inventories changed year-over-year?
- Aurinia Pharmaceuticals's change in inventories decreased by 89.7% year-over-year, from $6.97M to $720K.
- What is the long-term trend for Aurinia Pharmaceuticals's change in inventories?
- Over 2 years (2021 to 2023), Aurinia Pharmaceuticals's change in inventories has grown at a 67.7% compound annual growth rate (CAGR), from $5.64M to $15.87M.
- What does change in inventories mean?
- Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.